William Blair Downgrades VistaGen Therapeutics to Market Perform

William Blair analyst Tim Lugo downgrades VistaGen Therapeutics (NASDAQ:VTGN) from Outperform to Market Perform.

William Blair analyst Tim Lugo downgrades VistaGen Therapeutics (NASDAQ:VTGN) from Outperform to Market Perform.

Total
0
Shares
Related Posts